Fiscal year 2025 executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.
This is the complete answer, not a partial one — the list is never padded.
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Martin Lehr | $588,515 | $15,000 | $0 | $551,415 | $300,000 | $0 | $10,500 | $1,465,430 |
| Chief Executive Officer | ||||||||
| Jennifer Minai-Azary | 421,731 | 8,500 | 0 | 255,408 | 170,000 | 0 | 10,500 | 866,139 |
| Chief Financial Officer and Treasurer | ||||||||
| Alex Levit | 397,807 | 8,000 | 0 | 240,364 | 160,000 | 0 | 10,500 | 816,671 |
| Chief Legal Officer and Corporate Secretary | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Martin Lehr | $1,465,430 | — | — | — |
| Jennifer Minai-Azary | 866,139 | — | — | — |
| Alex Levit | 816,671 | — | — | — |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
No insider equity transactions reported since the proxy statement.
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Martin Lehr | Option | 10,596 | 1.79 | — |
| Martin Lehr | Option | 802,700 | 0.81 | — |
| Martin Lehr | Option | 83,867 | 0.84 | — |
| Martin Lehr | Option | 163,914 | 1.07 | — |
| Alex Levit | Option | 4,495 | 1.79 | — |
| Alex Levit | Option | 44,189 | 0.84 | — |
| Alex Levit | Option | 86,352 | 1.07 | — |
| Alex Levit | Option | 349,900 | 0.81 | — |
| Jennifer Minai-Azary | Option | 4,686 | 1.79 | — |
| Jennifer Minai-Azary | Option | 46,084 | 0.84 | — |
| Jennifer Minai-Azary | Option | 90,065 | 1.07 | — |
| Jennifer Minai-Azary | Option | 371,800 | 0.81 | — |
| CEO STI target (% of salary) | — |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Cannae HR Solutions |
| Clawback policy | true |
| Anti-hedging | — |
| Anti-pledging | — |
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Karen Smith, MDIndependent · Compensation (Chair) | $49,558 | $0 | $67,359 | — | $83,332 | $200,249 |
| Andy PasternakIndependent · Audit · Compensation | 65,739 | 0 | 93,288 | — | 0 | 159,027 |
| Linda WestIndependent · Audit (Chair) · Compensation | 60,000 | 0 | 67,359 | — | 0 | 127,359 |
| Jennifer Evans Stacey, EsqIndependent · Audit · Nominating and Corporate Governance (Chair) | 55,276 | 0 | 67,359 | — | 0 | 122,635 |
| Luke Walker, MDIndependent · Nominating and Corporate Governance | 43,776 | 0 | 67,359 | — | 0 | 111,135 |
| Philip Kantoff, MDIndependent · Nominating and Corporate Governance | 43,776 | 0 | 67,359 | — | 0 | 111,135 |
| Richard BermanIndependent · Departed during FY | 2,339 | 0 | 0 | — | 20,000 | 22,339 |
| Martin LehrEmployee director | — | — | — | — | — | 0 |
| Annual cash retainer | $40,000 |
|---|---|
| Annual equity retainer | $120,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 7,500 / 11,000 / 8,000 |
| Stock ownership guideline | — |
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $320,464 |
| Equity awards (grant-date value) | $0 |
| All other compensation | $103,332 |
| Total cost of the board | $423,796 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Context Therapeutics | 2025 | Martin Lehr | $588,515 | $0 | $551,415 | $300,000 | $1,465,430 |
Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.
| # | Supports | Document | Filed | Accession | Location in document |
|---|---|---|---|---|---|
| 1 | Section 01, Martin Lehr | DEF 14A | 2026-04-28 | 0001628280-26-027928 | Section “Executive Compensation”. As printed: 1,465,430. Filing ↗machine: r2 · c39 · span 296070–296079 |
| 2 | Section 01, Jennifer Minai-Azary | DEF 14A | 2026-04-28 | 0001628280-26-027928 | Section “Executive Compensation”. As printed: 866,139. Filing ↗machine: r6 · c39 · span 306944–306951 |
| 3 | Section 01, Alex Levit | DEF 14A | 2026-04-28 | 0001628280-26-027928 | Section “Executive Compensation”. As printed: 816,671. Filing ↗machine: r4 · c39 · span 301533–301540 |
| 4 | Section 08, Karen Smith, MD | DEF 14A | 2026-04-28 | 0001628280-26-027928 | Section “Director Compensation”. As printed: 200,249. Filing ↗machine: span 393838–393845 |
| 5 | Section 08, Andy Pasternak | DEF 14A | 2026-04-28 | 0001628280-26-027928 | Section “Director Compensation”. As printed: 159,027. Filing ↗machine: span 391706–391713 |
| 6 | Section 08, Linda West | DEF 14A | 2026-04-28 | 0001628280-26-027928 | Section “Director Compensation”. As printed: 127,359. Filing ↗machine: span 399545–399552 |
| 7 | Section 08, Jennifer Evans Stacey, Esq | DEF 14A | 2026-04-28 | 0001628280-26-027928 | Section “Director Compensation”. As printed: 122,635. Filing ↗machine: span 395750–395757 |
| 8 | Section 08, Luke Walker, MD | DEF 14A | 2026-04-28 | 0001628280-26-027928 | Section “Director Compensation”. As printed: 111,135. Filing ↗machine: span 397650–397657 |
| 9 | Section 08, Philip Kantoff, MD | DEF 14A | 2026-04-28 | 0001628280-26-027928 | Section “Director Compensation”. As printed: 111,135. Filing ↗machine: span 389807–389814 |
| 10 | Section 08, Richard Berman | DEF 14A | 2026-04-28 | 0001628280-26-027928 | Section “Director Compensation”. As printed: 22,339. Filing ↗machine: span 387879–387885 |
| 11 | Section 08, Martin Lehr | DEF 14A | 2026-04-28 | 0001628280-26-027928 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 12 | Section 09b board cost (computed) | Computed | — | computed | Cash 320,464 + equity 0 + all other 103,332 = 423,796, summed across the director compensation table rows.machine: formula: Σ = 423,796 |
| 13 | Context Therapeutics (subject), Section 10b CEO total | DEF 14A | 2026-04-28 | 0001628280-26-027928 | CEO total compensation as printed in Context Therapeutics's own proxy. As printed: 1,465,430. Filing ↗machine: r2 · c39 · span 296070–296079 |